The National Development and Reform Commission officially formulated and published the rules for the differential parity of drugs.

The reporter learned from the National Development and Reform Commission that after several years of trials, the National Development and Reform Commission formally announced the publication of the “Drug Compensatory Contrast Rule” (hereinafter referred to as the “Regulation”), which clearly stipulates the maximum retail sales between different formulations, specifications or packages of the same drug. The principle and method of price verification.

The National Development and Reform Commission stated that in recent years, pharmaceutical dosage forms, specifications, packaging materials and forms have been continuously refurbished, and some companies have increased the price of social medicine by changing the dosage form, specifications, or packaging, etc., in order to avoid price changes. In response to these problems, the National Development and Reform Commission (NDRC) researched and proposed a management method that “according to the generic name of pharmaceuticals, select the representative retail dosage form to establish the maximum retail price, and other dosage form specifications should be based on the representative product, and check the price according to the reasonable price comparison relationship”.

In accordance with the requirements of the "Regulations," prices for different formulations and specifications of the same type of drugs should be based on representative products and be verified in accordance with the established differential parity relationship. Among them, representative products are selected according to the principle of typical clinical use, reasonable price, and cost and supply and demand conditions. Drugs with the same active ingredients must not be based on different names, different packaging materials, etc. Price increase; Clearly stipulates the price-to-price relationship between clinically used dosage forms, prevents companies from changing prices by unreasonably changing dosage forms, and stipulates the relationship between different levels, quantities, and quantities of packaging to prevent companies from unreasonably increasing prices by changing specifications. price.

The National Development and Reform Commission stated that the formal implementation of the "Rules" will further enhance the scientific and transparent pricing of the government and will play an important role in regulating the behavior of drug prices and restraining companies from changing the formulation package and increasing the price in disguised form.